{
    "organizations": [],
    "uuid": "7fc1a7574103431fc0304a80c9fdd8ed98076b97",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-insys-therapeutics-to-advance-clin/brief-insys-therapeutics-to-advance-clinical-research-of-dronabinol-inhalation-using-novel-breath-actuated-device-idUSFWN1RV0G8",
    "ord_in_thread": 0,
    "title": "BRIEF-Insys Therapeutics To Advance Clinical Research Of Dronabinol Inhalation Using Novel Breath-Actuated Device",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 18 (Reuters) - INSYS Therapeutics Inc:\n* INSYS THERAPEUTICS TO ADVANCE CLINICAL RESEARCH OF DRONABINOL INHALATION USING NOVEL BREATH-ACTUATED DEVICE\n* INSYS THERAPEUTICS - PLANS TO ADVANCE CLINICAL RESEARCH OF DRONABINOL INHALATION, ACCEPTED BY U.S. FDA UNDER IND FILING IN H2 2018. Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-18T21:20:00.000+03:00",
    "crawled": "2018-04-19T15:19:06.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "insys",
        "therapeutic",
        "inc",
        "insys",
        "therapeutic",
        "advance",
        "clinical",
        "research",
        "dronabinol",
        "inhalation",
        "using",
        "novel",
        "device",
        "insys",
        "therapeutic",
        "plan",
        "advance",
        "clinical",
        "research",
        "dronabinol",
        "inhalation",
        "accepted",
        "fda",
        "ind",
        "filing",
        "h2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}